Leadership changes
Executive appointments and departures from SEC 8-K filings, updated within hours of each filing.
Updated Nov 6, 2026
Changes, November 2026
292
Appointments
147
Departures
32
Browse by role
Get new CFO appointments the day the filing lands.
Browse by month
Filters
3,404 changes
| Filing date | Company | Person | Role | Change | Effective date | Source |
|---|---|---|---|---|---|---|
| Sep 18, 2026 | Aerkomm Inc. | Jeff T.C. Hsu | member of the board of directorsmember of the board of directors | Departed | May 31, 2026 | SEC 8-K |
| Sep 18, 2026 | Aerkomm Inc. | Tayi Shen | member of the Boardmember of the Board | Appointed | Sep 14, 2026 | SEC 8-K |
| Sep 18, 2026 | AMERICAN TOWER CORP /MA/ | Kristen M. Ludgate | director and member of its Compensation and Human Capital Committeedirector and member of its Compensation and Human Capital Committee | Appointed | Sep 17, 2026 | SEC 8-K |
| Sep 18, 2026 | C1 Fund Inc. | David Hytha | Secretary, Treasurer and Chief Financial OfficerCFO | Departed | Dec 31, 2026 | SEC 8-K |
| Sep 18, 2026 | Concentrix Corp | Cormac Twomey | Executive Vice President, Customer SuccessExecutive Vice President, Customer Success | Departed | Dec 31, 2026 | SEC 8-K |
| Sep 18, 2026 | CREDITRISKMONITOR COM INC | Jennifer Gerold | Chief Financial OfficerCFO | Departed | Nov 17, 2026 | SEC 8-K |
| Sep 18, 2026 | FARMERS NATIONAL BANC CORP /OH/ | Myke Matuszak | Senior Executive Vice President and Chief Operating OfficerCOO | Departed | Oct 15, 2026 | SEC 8-K |
| Sep 18, 2026 | First Carolina Financial Services, Inc. | Steven G. Deaton | Chief Financial Officer and Chief Risk OfficerCFO | Departed | Jan 1, 2027 | SEC 8-K |
| Sep 18, 2026 | Genpact LTD | Michael Weiner | Chief Financial OfficerCFO | Departed | Sep 8, 2026 | SEC 8-K |
| Sep 18, 2026 | Glucotrack, Inc. | Paul V. Goode | DirectorDirector | Departed | Sep 14, 2026 | SEC 8-K |
| Sep 18, 2026 | Gold.com, Inc. | Cary Dickson | Executive Vice President and Chief Financial OfficerCFO | Departed | Sep 18, 2026 | SEC 8-K |
| Sep 18, 2026 | Gold.com, Inc. | Jill Van | Chief Financial OfficerCFO | Appointed | Sep 18, 2026 | SEC 8-K |
| Sep 18, 2026 | HEALTHY EXTRACTS INC. | Bill Croyle | DirectorDirector | Departed | Sep 13, 2026 | SEC 8-K |
| Sep 18, 2026 | Inhibitor Therapeutics, Inc. | Francis E. O’Donnell | DirectorDirector | Appointed | Sep 15, 2026 | SEC 8-K |
| Sep 18, 2026 | Inhibitor Therapeutics, Inc. | Samuel J. Sears | DirectorDirector | Appointed | Sep 15, 2026 | SEC 8-K |
| Sep 18, 2026 | Inhibitor Therapeutics, Inc. | Niraj Vasisht | DirectorDirector | Appointed | Sep 15, 2026 | SEC 8-K |
| Sep 18, 2026 | Inhibitor Therapeutics, Inc. | Michelle Yanez | DirectorDirector | Appointed | Sep 15, 2026 | SEC 8-K |
| Sep 18, 2026 | Inhibitor Therapeutics, Inc. | Michael Jerman | DirectorDirector | Appointed | Sep 15, 2026 | SEC 8-K |
| Sep 18, 2026 | Inhibitor Therapeutics, Inc. | Ronald E. Osman | DirectorDirector | Appointed | Sep 15, 2026 | SEC 8-K |
| Sep 18, 2026 | INTELLINETICS, INC. | Matthew Chretien | Chief Strategy OfficerChief Strategy Officer | Departed | Sep 1, 2026 | SEC 8-K |
- Aerkomm Inc.Departed
Jeff T.C. Hsu member of the board of directors
Filed Sep 18, 2026Effective May 31, 2026SEC 8-K
- Aerkomm Inc.Appointed
Tayi Shen member of the Board
Filed Sep 18, 2026Effective Sep 14, 2026SEC 8-K
- AMERICAN TOWER CORP /MA/Appointed
Kristen M. Ludgate director and member of its Compensation and Human Capital Committee
Filed Sep 18, 2026Effective Sep 17, 2026SEC 8-K
- C1 Fund Inc.Departed
David Hytha CFO
Filed Sep 18, 2026Effective Dec 31, 2026SEC 8-K
- Concentrix CorpDeparted
Cormac Twomey Executive Vice President, Customer Success
Filed Sep 18, 2026Effective Dec 31, 2026SEC 8-K
- CREDITRISKMONITOR COM INCDeparted
Jennifer Gerold CFO
Filed Sep 18, 2026Effective Nov 17, 2026SEC 8-K
- FARMERS NATIONAL BANC CORP /OH/Departed
Myke Matuszak COO
Filed Sep 18, 2026Effective Oct 15, 2026SEC 8-K
Steven G. Deaton CFO
Filed Sep 18, 2026Effective Jan 1, 2027SEC 8-K
- Genpact LTDDeparted
Michael Weiner CFO
Filed Sep 18, 2026Effective Sep 8, 2026SEC 8-K
- Glucotrack, Inc.Departed
Paul V. Goode Director
Filed Sep 18, 2026Effective Sep 14, 2026SEC 8-K
- Gold.com, Inc.Departed
Cary Dickson CFO
Filed Sep 18, 2026Effective Sep 18, 2026SEC 8-K
- Gold.com, Inc.Appointed
Jill Van CFO
Filed Sep 18, 2026Effective Sep 18, 2026SEC 8-K
- HEALTHY EXTRACTS INC.Departed
Bill Croyle Director
Filed Sep 18, 2026Effective Sep 13, 2026SEC 8-K
- Inhibitor Therapeutics, Inc.Appointed
Francis E. O’Donnell Director
Filed Sep 18, 2026Effective Sep 15, 2026SEC 8-K
- Inhibitor Therapeutics, Inc.Appointed
Samuel J. Sears Director
Filed Sep 18, 2026Effective Sep 15, 2026SEC 8-K
- Inhibitor Therapeutics, Inc.Appointed
Niraj Vasisht Director
Filed Sep 18, 2026Effective Sep 15, 2026SEC 8-K
- Inhibitor Therapeutics, Inc.Appointed
Michelle Yanez Director
Filed Sep 18, 2026Effective Sep 15, 2026SEC 8-K
- Inhibitor Therapeutics, Inc.Appointed
Michael Jerman Director
Filed Sep 18, 2026Effective Sep 15, 2026SEC 8-K
- Inhibitor Therapeutics, Inc.Appointed
Ronald E. Osman Director
Filed Sep 18, 2026Effective Sep 15, 2026SEC 8-K
- INTELLINETICS, INC.Departed
Matthew Chretien Chief Strategy Officer
Filed Sep 18, 2026Effective Sep 1, 2026SEC 8-K